A punch in the gut - Intestinal inflammation links environmental factors to neurodegeneration in Parkinson's disease.

Calprotectin Crohn's disease Inflammatory bowel disease Intestinal inflammation NOD2 Parkinson's disease Short chain fatty acids

Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
03 2019
Historique:
received: 03 07 2018
revised: 31 08 2018
accepted: 28 09 2018
pubmed: 8 10 2018
medline: 6 5 2020
entrez: 8 10 2018
Statut: ppublish

Résumé

Parkinson's disease (PD) is an etiologically heterogeneous disorder. Experimental, clinical and epidemiological data suggest that intestinal inflammation contributes to the pathogenesis of PD. This article reviews recent literature on gut microbiota and intestinal inflammation in PD. We propose that intestinal inflammation links environmental factors (e.g. an altered gut microbiota composition) to neurodegeneration in (genetically susceptible) PD patients. In addition, there is an epidemiological and genetic overlap between PD and inflammatory bowel disease. This overlap provides an opportunity to develop new treatment strategies for at least a subgroup of PD patients.

Identifiants

pubmed: 30292735
pii: S1353-8020(18)30428-0
doi: 10.1016/j.parkreldis.2018.09.032
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-45

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Anouck Becker (A)

Department of Neurology, Saarland University, Homburg, Germany.

Klaus Faßbender (K)

Department of Neurology, Saarland University, Homburg, Germany.

Wolfgang H Oertel (WH)

Department of Neurology, Philipps University Marburg, Germany; Institute for Neurogenomics, Helmholtz Institute, Neuherberg, Germany.

Marcus M Unger (MM)

Department of Neurology, Saarland University, Homburg, Germany. Electronic address: marcus.unger@me.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH